AGY

DIETARY_SUPPLEMENT2 trials

Sponsors

Igy Inc.

Conditions

Celiac Disease

Phase 1

Oral AGY for Celiac Disease

CompletedNCT01765647

Igy Inc.Celiac Disease

Start: 2014-05-31End: 2015-08-31Updated: 2019-12-13

Phase 2

A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease

CompletedNCT03707730

Igy Inc.Celiac Disease

Start: 2019-10-29End: 2023-12-31Updated: 2024-03-06